AI assistant
Sending…
RELMADA THERAPEUTICS, INC. — Director's Dealing 2015
Dec 17, 2015
34465_dirs_2015-12-17_6c1dea8f-293a-44ba-88d3-42a10bf8a0c0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
CIK: 0001553643
Period of Report: 2015-12-15
Reporting Person: SETH SANDESH (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-15 | Common stock | P | 2500 | $3 | Acquired | 116258 | Direct |
| 2015-12-15 | Common stock | P | 2000 | $2.91 | Acquired | 118258 | Direct |
| 2015-12-15 | Common stock | P | 2500 | $3.3 | Acquired | 120758 | Direct |
| 2015-12-15 | Common stock | P | 100 | $3.43 | Acquired | 120858 | Direct |
| 2015-12-15 | Common stock | P | 2400 | $3.5 | Acquired | 123258 | Direct |
More from RELMADA THERAPEUTICS, INC.
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 12
Regulatory Filings
2026
Jan 30
Director's Dealing
2025
Dec 16